5026 - 5050 of 9145 Results
Title
Year
-
OPENTitle: Distal Covalent Targeting Suppresses Signaling of Oncogenic K-Ras(G13C) in Cancer CellsJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 20Issue #: 7Start Page: 1696End Page: 1706Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschembio.5c00249Best OA location URL: https://doi.org/10.1021/acschembio.5c00249Citation Count: 3
-
OPENTitle: An augmented reality dual-task intervention improves postural stability in individuals with Parkinson’s diseaseJournal Name: Gait & PosturePublisher: Elsevier BVVol: 115Issue #:Start Page: 102End Page: 108Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.gaitpost.2024.11.007Best OA location URL: https://doi.org/10.1016/j.gaitpost.2024.11.007Citation Count: 7
- A comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonism2013RESTRICTEDTitle: A comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonismJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 5Start Page: 1125End Page: 1131Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2013.11.015Citation Count: 93
- Letter in response to Cole-Hunter et al., 2023: What does “Parkinson’s disease mortality” mean?2023OPENTitle: Letter in response to Cole-Hunter et al., 2023: What does “Parkinson’s disease mortality” mean?Journal Name: Environment InternationalPublisher: Elsevier BVVol: 173Issue #:Start Page: 107852End Page: 107852Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.envint.2023.107852Best OA location URL: https://doi.org/10.1016/j.envint.2023.107852Citation Count: 1
- No anti-IgLON5 antibody in carefully diagnosed PSP patients with “atypical” or variant clinical features2025RESTRICTEDTitle: No anti-IgLON5 antibody in carefully diagnosed PSP patients with “atypical” or variant clinical featuresJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 140Issue #:Start Page: 108071End Page: 108071Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108071Citation Count: 0
-
OPENTitle: Simultaneous Determination of the Size and Shape of Single α-Synuclein Oligomers in SolutionJournal Name: ACS NanoPublisher: American Chemical Society (ACS)Vol: 17Issue #: 13Start Page: 12325End Page: 12335Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acsnano.3c01393Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acsnano.3c01393Citation Count: 51
-
OPENTitle: The MDS−UPDRS tracks motor and non-motor improvement due to subthalamic nucleus deep brain stimulation in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 19Issue #: 11Start Page: 966End Page: 969Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2013.06.010Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3825788Citation Count: 81
-
OPENTitle: Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in miceJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.28377Best OA location URL: https://doi.org/10.7554/elife.28377Citation Count: 112
- Can we accurately classify schizophrenia patients from healthy controls using magnetic resonance imaging and machine learning? A multi-method and multi-dataset study2017OPENTitle: Can we accurately classify schizophrenia patients from healthy controls using magnetic resonance imaging and machine learning? A multi-method and multi-dataset studyJournal Name: Schizophrenia ResearchPublisher: Elsevier BVVol: 214Issue #:Start Page: 3End Page: 10Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.schres.2017.11.038Citation Count: 86
- Mindfulness based stress reduction in people with Parkinson's disease and their care partners2021RESTRICTEDTitle: Mindfulness based stress reduction in people with Parkinson's disease and their care partnersJournal Name: Complementary Therapies in Clinical PracticePublisher: Elsevier BVVol: 43Issue #:Start Page: 101377End Page: 101377Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ctcp.2021.101377Citation Count: 17
- The kainate receptor antagonist UBP310 but not single deletion of GluK1, GluK2, or GluK3 subunits, inhibits MPTP-induced degeneration in the mouse midbrain2019OPENTitle: The kainate receptor antagonist UBP310 but not single deletion of GluK1, GluK2, or GluK3 subunits, inhibits MPTP-induced degeneration in the mouse midbrainJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 323Issue #:Start Page: 113062End Page: 113062Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2019.113062Citation Count: 19
- Kinematic Adaptive Deep Brain Stimulation for Resting Tremor in Parkinson's Disease2016RESTRICTEDTitle: Kinematic Adaptive Deep Brain Stimulation for Resting Tremor in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 3Start Page: 426End Page: 428Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26482Citation Count: 135
- Selective Fluorogenic β-Glucocerebrosidase Substrates for Convenient Analysis of Enzyme Activity in Cell and Tissue Homogenates2020OPENTitle: Selective Fluorogenic β-Glucocerebrosidase Substrates for Convenient Analysis of Enzyme Activity in Cell and Tissue HomogenatesJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 15Issue #: 4Start Page: 824End Page: 829Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschembio.9b01044Citation Count: 13
-
OPENTitle: Neuron-derived extracellular vesicles to examine brain mTOR target engagement with sirolimus in patients with multiple system atrophyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 115Issue #:Start Page: 105821End Page: 105821Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105821Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10592064/pdf/nihms-1927641.pdfCitation Count: 9
-
OPENTitle: Cell-free mitochondrial DNA deletions in idiopathic, but not LRRK2, Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 174Issue #:Start Page: 105885End Page: 105885Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105885Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105885Citation Count: 19
-
RESTRICTEDTitle: A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer’s DiseaseJournal Name: Cell SystemsPublisher: Elsevier BVVol: 4Issue #: 1Start Page: 60End Page: 72.e4Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cels.2016.11.006Best OA location URL: http://doi.org/10.1016/j.cels.2016.11.006Citation Count: 538
-
OPENTitle: Vaccines mimicking conformational epitopes on α-synuclein fibrils provide immunity to Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 149Issue #: 8Start Page: 2689End Page: 2701Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awag010Best OA location URL: https://doi.org/10.1093/brain/awag010Citation Count: 3
-
OPENTitle: Weighted Protein Interaction Network Analysis of Frontotemporal DementiaJournal Name: Journal of Proteome ResearchPublisher: American Chemical Society (ACS)Vol: 16Issue #: 2Start Page: 999End Page: 1013Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/acs.jproteome.6b00934Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.jproteome.6b00934Citation Count: 45
-
OPENTitle: Development of a Positron Emission Tomography Radiotracer for Imaging Elevated Levels of Superoxide in NeuroinflammationJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 9Issue #: 3Start Page: 578End Page: 586Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.7b00385Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5865080Citation Count: 78
-
OPENTitle: Impact of inpatient mobility on outcomes in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 135Issue #:Start Page: 107834End Page: 107834Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107834Best OA location URL: https://doi.org/10.1016/j.parkreldis.2025.107834Citation Count: 1
-
OPENTitle: Experiences of Pacific Peoples and their ‘āiga/kāinga/kāiga/vuvale living with Parkinsons: A qualitative studyJournal Name: PLOS OnePublisher: Public Library of Science (PLoS)Vol: 21Issue #: 8Start Page: e0355989End Page: e0355989Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0355989Best OA location URL: https://doi.org/10.1371/journal.pone.0355989Citation Count: 0
- Synthesis of Multiring Fused 2-Pyridones via a Nitrene Insertion Reaction: Fluorescent Modulators of α-Synuclein Amyloid Formation2015RESTRICTEDTitle: Synthesis of Multiring Fused 2-Pyridones via a Nitrene Insertion Reaction: Fluorescent Modulators of α-Synuclein Amyloid FormationJournal Name: Organic LettersPublisher: American Chemical Society (ACS)Vol: 17Issue #: 24Start Page: 6194End Page: 6197Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.orglett.5b03190Citation Count: 20
-
OPENTitle: Transglutaminase 2 Depletion Attenuates α-Synuclein Mediated Toxicity in MiceJournal Name: NeurosciencePublisher: Elsevier BVVol: 441Issue #:Start Page: 58End Page: 64Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuroscience.2020.05.047Best OA location URL: https://doi.org/10.1016/j.neuroscience.2020.05.047Citation Count: 22
-
OPENTitle: Skin conditions in early Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 84Issue #:Start Page: 40End Page: 46Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.01.018Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8900714Citation Count: 4
-
OPENTitle: Parkinson's disease progression is shaped by longitudinal changes in cerebral compensationJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 149Issue #: 1Start Page: 194End Page: 208Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awaf302Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awaf302/64029765/awaf302.pdfCitation Count: 6